In Vitro Anti-HMPV Activity of Meroditerpenoids from Marine Alga Stypopodium zonale (Dictyotales)

Mendes, Gabriella; Soares, Angélica Ribeiro; Sigiliano, Lorena; Machado, Fernanda; Kaiser, Carlos; Romeiro, Nelilma; Gestinari, Lísia; Santos, Norma; Romanos, Maria Teresa Villela
October 2011
Molecules;Oct2011, Vol. 16 Issue 10, p8437
Academic Journal
In this paper, we evaluated the antiviral activity against HMPV replication of crude extract of the marine algae Stypopodium zonale and of two meroditerpenoids obtained from it, atomaric acid and epitaondiol, and a methyl ester derivative of atomaric acid. Their selectivity indexes were 20.78, >56.81, 49.26 and 12.82, respectively. Compared to ribavirin, the substances showed a relatively low cytotoxicity on LLC-MK2 cells, with a significant antiviral activity, inhibiting at least 90% of viral replication in vitro, which demonstrates the potential of these marine natural products to combat infections caused by HMPV in vitro.


Related Articles

  • Biotic and abiotic degradation of pesticide Dufulin in soils. Wang, Hua; Zuo, Hai; Ding, Ya; Miao, Shan; Jiang, Chen; Yang, Hong // Environmental Science & Pollution Research;Mar2014, Vol. 21 Issue 6, p4331 

    Dufulin is a newly developed antiviral agent (or pesticide) that activates systemic acquired resistance of plants. This pesticide is widely used in China to prevent abroad viral diseases in rice, tobacco and vegetables. In this study, the potential impacts such as soil type, moisture,...

  • Ribavirin for combined use.  // WHO Drug Information;2001, Vol. 15 Issue 2, p79 

    Reports on the U.S. Food and Drug Administration's approval of ribavirin (Rebetol) capsules, an antiviral used with interferon alfa-2b for the treatment of patients with chronic hepatitis C infection. Stand-alone package of ribavirin; Most important side effect of ribavirin.

  • Pegylated Interferon and Ribavirin Treatment for Hepatitis C Virus Infection. Kagawa, Tatehiro; Keeffe, Emmet B.; Ming-Lung Yu // Hepatitis Research & Treatment;2010, p1 

    An introduction is presented in which the editors discussed various reports published within the issue on topics including the efficacy of interferon in treating chronic hepatitis C, comparison between pegylated interferon with ribavirin, and the side effects of antiviral agents on patients with...

  • Peginterferon-α-2a/ribavirin.  // Reactions Weekly;9/7/2013, Issue 1468, p31 

    The article presents a case study of a 43-year-old male patient who developed pulmonary sarcoidosis during antiviral treatment with peginterferon-beta-2a and ribavirin for chronic hepatitis C infection.

  • Nutritional and Chemical Composition and Antiviral Activity of Cultivated Seaweed Sargassum naozhouense Tseng et Lu. Yan Peng; Enyi Xie; Kai Zheng; Fredimoses, Mangaladoss; Xianwen Yang; Xuefeng Zhou; Yifei Wang; Bin Yang; Xiuping Lin; Juan Liu; Yonghong Liu // Marine Drugs;Jan2013, Vol. 11 Issue 1, p20 

    Sargassum naozhouense is a brown seaweed used in folk medicine and applied for thousands of years in Zhanjiang, Guangdong province, China. This study is the first time to investigate its chemical composition and antiviral activity. On the dry weight basis, this seaweed was constituted of ca....

  • Screening Of Antiviral Activity Of Some Terrestrial Leaf Plants Against Acyclovir- Resistant Hsv Type-1 In Cell Culture. Shoeib, A. R. S.; Zarouk, A. W.; El-Esnawy, N. A. // Australian Journal of Basic & Applied Sciences;2011, Vol. 5 Issue 10, p75 

    Infections due to Acyclovir (ACV) resistant Herpes Simplex Virus Type 1 (HSV-1) represent an important clinical concern in immunocompromised patients. So, resistance to ACV urged scientists to search for alternatives to the ACV from natural sources. To achieve this aim ACV resistant HSV-1 sample...

  • More AEs with addition of ribavirin in phase III ION trials.  // Reactions Weekly;Aug2015, Vol. 1565 Issue 1, p7 

    The article reports on data from the phase III ION trials, which shows that the incidence of adverse events (AEs) is increased by the addition of ribavirin (RBV) to ledipasvir/sofosbuvir, without providing additional efficacy.

  • Antiviral treatment of SARS: Can we draw any conclusions? Zhaori, Getu // CMAJ: Canadian Medical Association Journal;11/25/2003, Vol. 169 Issue 11, p1165 

    Presents opinion on the antiviral therapy of severe acute respiratory syndrome (SARS). Experience with empirical treatment of SARS with ribavirin; Regimens that could be used or another outbreak of SARS.

  • Current Advances in Anti-Influenza Therapy. Saladino, R.; Barontini, M.; Crucianelli, M.; Nencioni, L.; Sgarbanti, R.; Palamara, A. T. // Current Medicinal Chemistry;Jul2010, Vol. 17 Issue 20, p2101 

    Every year, influenza epidemics cause numerous deaths and millions of hospitalizations, but the most frightening effects are seen when new strains of the virus emerge from different species (e.g. the swine-origin influenza A/H1N1 virus), causing world-wide outbreaks of infection. Several...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics